Effects of adalimumab added to treat-to-target strategy with methotrexate and intra-articular triamcinolone on lipids in early- and treatment naïve rheumatoid arthritis patients: Secondary analyses from the multicenter double-blind, randomized, placebo-controlled Opera trial

D Masic; K Stengaard-Pedersen; BB Logstrup; Horslev-Petersen K; Merete Lund Hetland; P Junker; Mikkel Østergaard; C Ammitzbol; S Moller; R Christensen; T Ellingsen

Effects of adalimumab added to treat-to-target strategy with methotrexate and intra-articular triamcinolone on lipids in early- and treatment naïve rheumatoid arthritis patients: Secondary analyses from the multicenter double-blind, randomized, placebo-controlled Opera trial

D Masic, K Stengaard-Pedersen, BB Logstrup, Horslev-Petersen K, Merete Lund Hetland, P Junker, Mikkel Østergaard, C Ammitzbol, S Moller, R Christensen, T Ellingsen

Department for Rheumatology and Spine Diseases

Original language	Danish
Article number	FRI0069
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue number	Supple. 1
Pages (from-to)	611
Number of pages	1
ISSN	0003-4967
Publication status	Published - 2020

Cite this

Masic, D., Stengaard-Pedersen, K., Logstrup, BB., K, H.-P., Hetland, M. L., Junker, P., Østergaard, M., Ammitzbol, C., Moller, S., Christensen, R., & Ellingsen, T. (2020). Effects of adalimumab added to treat-to-target strategy with methotrexate and intra-articular triamcinolone on lipids in early- and treatment naïve rheumatoid arthritis patients: Secondary analyses from the multicenter double-blind, randomized, placebo-controlled Opera trial. Annals of the Rheumatic Diseases, 79(Supple. 1), 611. Article FRI0069.

Effects of adalimumab added to treat-to-target strategy with methotrexate and intra-articular triamcinolone on lipids in early- and treatment naïve rheumatoid arthritis patients: Secondary analyses from the multicenter double-blind, randomized, placebo-controlled Opera trial. / Masic, D; Stengaard-Pedersen, K; Logstrup, BB et al.
In: Annals of the Rheumatic Diseases, Vol. 79, No. Supple. 1, FRI0069, 2020, p. 611.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Masic, D, Stengaard-Pedersen, K, Logstrup, BB, K, H-P, Hetland, ML, Junker, P, Østergaard, M, Ammitzbol, C, Moller, S, Christensen, R & Ellingsen, T 2020, 'Effects of adalimumab added to treat-to-target strategy with methotrexate and intra-articular triamcinolone on lipids in early- and treatment naïve rheumatoid arthritis patients: Secondary analyses from the multicenter double-blind, randomized, placebo-controlled Opera trial', Annals of the Rheumatic Diseases, vol. 79, no. Supple. 1, FRI0069, pp. 611.

Masic D, Stengaard-Pedersen K, Logstrup BB, K HP, Hetland ML, Junker P et al. Effects of adalimumab added to treat-to-target strategy with methotrexate and intra-articular triamcinolone on lipids in early- and treatment naïve rheumatoid arthritis patients: Secondary analyses from the multicenter double-blind, randomized, placebo-controlled Opera trial. Annals of the Rheumatic Diseases. 2020;79(Supple. 1):611. FRI0069.

Masic, D ; Stengaard-Pedersen, K ; Logstrup, BB et al. / Effects of adalimumab added to treat-to-target strategy with methotrexate and intra-articular triamcinolone on lipids in early- and treatment naïve rheumatoid arthritis patients: Secondary analyses from the multicenter double-blind, randomized, placebo-controlled Opera trial. In: Annals of the Rheumatic Diseases. 2020 ; Vol. 79, No. Supple. 1. pp. 611.

@article{a2de80f209f54f85af1b2bdf53871b81,

title = "Effects of adalimumab added to treat-to-target strategy with methotrexate and intra-articular triamcinolone on lipids in early- and treatment na{\"i}ve rheumatoid arthritis patients: Secondary analyses from the multicenter double-blind, randomized, placebo-controlled Opera trial",

author = "D Masic and K Stengaard-Pedersen and BB Logstrup and Horslev-Petersen K and Hetland, {Merete Lund} and P Junker and Mikkel {\O}stergaard and C Ammitzbol and S Moller and R Christensen and T Ellingsen",

note = "COPECARE",

year = "2020",

language = "Dansk",

volume = "79",

pages = "611",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Supple. 1",

}

TY - ABST

T1 - Effects of adalimumab added to treat-to-target strategy with methotrexate and intra-articular triamcinolone on lipids in early- and treatment naïve rheumatoid arthritis patients: Secondary analyses from the multicenter double-blind, randomized, placebo-controlled Opera trial

AU - Masic, D

AU - Stengaard-Pedersen, K

AU - Logstrup, BB

AU - K, Horslev-Petersen

AU - Hetland, Merete Lund

AU - Junker, P

AU - Østergaard, Mikkel

AU - Ammitzbol, C

AU - Moller, S

AU - Christensen, R

AU - Ellingsen, T

N1 - COPECARE

PY - 2020

Y1 - 2020

M3 - Konferenceabstrakt i tidsskrift

SN - 0003-4967

VL - 79

SP - 611

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Supple. 1

M1 - FRI0069

ER -